Literature DB >> 15595932

Prevalence of Parkinson's disease in Sydney.

D K Y Chan1, D Cordato, M Karr, B Ong, H Lei, J Liu, W T Hung.   

Abstract

OBJECTIVE: To examine the prevalence of Parkinson's disease (PD) in Bankstown, Sydney, using the same methodology as a previous study in Randwick, Sydney, Australia (1998-1999). PARTICIPANTS AND METHODS: Twenty census districts (CDs) for the Bankstown local government area were randomly selected. Research personnel door-knocked every household within the CDs to locate people aged > or =55 years. A structured questionnaire (containing four screening questions for PD) was administered to those agreeing to participate. Screened positive participants were invited to come for a clinical examination. This is a continuation of the previous study and data have been combined.
RESULTS: Combining data for Bankstown and Randwick gave 1028 participants; crude prevalence, 780 per 100,000 (CI: 546-1077). In Bankstown, there were 501 participants aged > or =55 years (response rate 70%); 135 were screened positive with 101 (74.8%) agreeing to a clinical examination. The prevalence of PD in the Bankstown community was 3.4% (17 of 501) (95% CI: 1.98-5.43) for those aged > or =55 years; crude prevalence 776 per 100,000 (CI: 452-1241).
CONCLUSION: The combined results of two Sydney studies appear to indicate that Sydney has one of the highest prevalence estimates of PD in developed countries. Blackwell Munksgaard 2004

Entities:  

Mesh:

Year:  2005        PMID: 15595932     DOI: 10.1111/j.1600-0404.2004.00348.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson's Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration.

Authors:  A Kh Alieva; V S Zyrin; M M Rudenok; A A Kolacheva; M V Shulskaya; M V Ugryumov; P A Slominsky; M I Shadrina
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

2.  Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.

Authors:  Anelya Kh Alieva; Elena V Filatova; Anna A Kolacheva; Margarita M Rudenok; Petr A Slominsky; Mikhail V Ugrumov; Maria I Shadrina
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

3.  Self-reported parkinsonian symptoms in the EPIC-Norfolk cohort.

Authors:  Lianna S Ishihara; Kay-Tee Khaw; Robert Luben; Sheila Bingham; Ailsa Welch; Nicholas Day; Carol Brayne
Journal:  BMC Neurol       Date:  2005-08-24       Impact factor: 2.474

4.  Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study.

Authors:  Seyed-Mohammad Fereshtehnejad; Mahdiyeh Shafieesabet; Arash Rahmani; Ahmad Delbari; Johan Lökk
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-05       Impact factor: 2.570

5.  Parkinson's disease in Germany: prevalence and incidence based on health claims data.

Authors:  M Nerius; A Fink; G Doblhammer
Journal:  Acta Neurol Scand       Date:  2016-10-10       Impact factor: 3.209

6.  Epidemiology of Parkinson's disease.

Authors:  Meike Kasten; Annabel Chade; Caroline M Tanner
Journal:  Handb Clin Neurol       Date:  2007

Review 7.  Systematic review of the prevalence and incidence of Parkinson's disease in Asia.

Authors:  Weerasak Muangpaisan; Hiroyuki Hori; Carol Brayne
Journal:  J Epidemiol       Date:  2009-10-03       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.